Publications by authors named "O Sofer"

Claim this Profile
P
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Irit Avivi, Chava Perry, Yafit Segman, Odelia Amit, Yaeli Bar-On, Orit Sofer

Ann Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.
Ilana Levy, Avital Lavi, Eran Zimran, Sigal Grisariu, Shlomzion Aumann, Orit Sofer

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib Treatment and EGFR-mutant Lung Adenocarcinoma.
Katerina Shulman, Olga Kazarin, Elias Tannous, Orit Sofer

Isr Med Assoc J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.
Yafit Segman, Elena Ribakovsky, Abraham Avigdor, Yair Goldhecht, Vladimir Vainstein, Orit Sofer

Leuk Lymphoma· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study.
Chava Perry, Sharon Ben Barouch, Neta Goldschmidt, Nadav Sarid, Yair Herishanu, Orit Sofer

Am J Hematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis